Elicio Therapeutics Inc.

ELTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.91

+$0.02 (+1.06%)

At close: Sep 21, 2026, 4:00 PM ET

$1.93

+$0.02 (+1.05%)

Pre-market: Sep 22, 2026, 7:41 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $36.42M

Enterprise Value $17.55M

Beta 1.86

Average Volume 1.61M

Shares Outstanding (Diluted) 19.24M

Shares Change YoY 19.83%

Institutional Ownership 14.50%

Exchange NASDAQ

ISIN US28657F1030

Price Performance

Price Change 1M -37.6%

Price Change 3M -53.5%

Price Change 6M -82.6%

Price Change YTD -76.3%

Price Change 1Y -82.8%

Price Change 3Y -67.7%

Price Change 5Y -67.7%

1M CAGR (ann.) -40.1%

1Y CAGR (ann.) -83.3%

5Y CAGR (ann.) N/A

All-Time CAGR -32.6%

Valuation

PE Ratio -0.90

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.14

PS Ratio N/A

Forward PS N/A

PB Ratio 4.59

P/FCF Ratio -0.97

P/Adj. FCF Ratio -0.89

P/OCF Ratio -0.97

EV/Sales N/A

EV/EBIT -0.62

EV/EBITDA -0.46

EV/FCF -0.47

Earnings Yield -111.5%

FCF Yield -103.5%

Adj. FCF Yield -112.5%

Financial Health

Net Cash $18.87M

Total Debt $4.61M

Cash & Short-Term Investments $23.48M

Total Assets $31.33M

Current Ratio 2.77

Quick Ratio 2.77

Debt / Equity Ratio 1.78

Debt / EBITDA -0.12

Debt / FCF -0.12

OCF / Debt -8.17

Interest Coverage -24.00

Altman Z-Score -12.78

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.7%

Returns

Return on Assets -120.8%

Return on Equity -1266.4%

Return on Invested Capital -163.4%

Return on Capital Employed -171.4%

Return on Tangible Assets -120.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 41.6%

EPS CAGR 5Y 28.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -2.0%

FCF CAGR 5Y -0.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 3

EPS Growth Next 3Y -29.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.52

EPS Growth Est (next Q) -13.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11.83

Price Target Upside 519.4%

Cash Flow

Operating Cash Flow $-37.69M

Free Cash Flow $-37.71M

Adj. Free Cash Flow $-40.98M

FCF Per Share -$1.96

OCF Per Share -$1.96

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-289K

Operating Income $-37.92M

EBITDA $-38.03M

Net Income $-37.84M

EPS (Diluted) -$2.13

Revenue / Employee N/A

Profit / Employee $-1.15M

Employees 33